becatecarin

DRUG13 trials

Sponsors

Memorial Sloan Kettering Cancer Center, National Cancer Institute (NCI), Barbara Ann Karmanos Cancer Institute, Case Comprehensive Cancer Center, Northwestern University

Conditions

Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Inv(16)(p13;q22)Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)Biliary Tract CancerBlastic Phase Chronic Myelogenous LeukemiaBrain and Central Nervous System Tumors

Phase 1

Rebeccamycin Analog and Cisplatin With or Without Filgrastim in Treating Patients With Advanced Cancer

CompletedNCT00004189

National Cancer Institute (NCI)Lymphoma, Small Intestine Cancer, Unspecified Adult Solid Tumor, Protocol Specific

Start: 1999-10-31Updated: 2013-02-11

Rebeccamycin Analog in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia

CompletedNCT00087204

National Cancer Institute (NCI)Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) +13

Start: 2004-05-31Updated: 2013-01-23

Rebeccamycin Analog and Oxaliplatin in Treating Patients With Refractory Solid Tumors

TerminatedNCT00086983

National Cancer Institute (NCI)Unspecified Adult Solid Tumor, Protocol Specific

Start: 2004-05-31Target: 15Updated: 2013-01-10

Phase 2

Two Rebeccamycin Analogue Regimens in Treating Patients With Advanced or Recurrent Non-small Cell Lung Cancer

CompletedNCT00006017

Case Comprehensive Cancer CenterLung Cancer

Start: 2000-05-31End: 2005-01-31Updated: 2010-06-10

Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's Lymphoma

CompletedNCT00006102

National Cancer Institute (NCI)Brain and Central Nervous System Tumors, Lymphoma, Neuroblastoma +3

Start: 2000-07-31Updated: 2013-02-05

Rebeccamycin Analogue in Treating Patients With Advanced Liver and/or Biliary Cancer

TerminatedNCT00005997

Case Comprehensive Cancer CenterExtrahepatic Bile Duct Cancer, Gallbladder Cancer, Liver Cancer

Start: 1999-04-30End: 2005-11-30Updated: 2010-06-11

Rebeccamycin Analogue in Treating Women With Stage IIIB or Stage IV Breast Cancer

CompletedNCT00005817

National Cancer Institute (NCI)Male Breast Cancer, Recurrent Breast Cancer, Stage IIIB Breast Cancer +1

Start: 2000-03-31Updated: 2013-02-01

Rebeccamycin Analog in Treating Children With Relapsed or Refractory Neuroblastoma

CompletedNCT00003737

Memorial Sloan Kettering Cancer CenterNeuroblastoma

Start: 1999-01-31End: 2006-09-30Target: 30Updated: 2013-06-25

Rebeccamycin Analog in Treating Patients With Advanced Kidney Cancer

CompletedNCT00005027

Barbara Ann Karmanos Cancer InstituteKidney Cancer

Start: 2000-06-30End: 2005-03-31Updated: 2013-04-05

Rebeccamycin Analog in Treating Patients With Metastatic or Locally Recurrent Colorectal Cancer

CompletedNCT00005085

National Cancer Institute (NCI)Colorectal Cancer

Start: 2000-02-29Updated: 2013-02-11

Rebeccamycin Analogue in Treating Patients With Refractory Stage III or Stage IV Ovarian Epithelial Cancer

TerminatedNCT00006262

Northwestern UniversityOvarian Cancer

Start: 2000-07-31End: 2001-09-30Updated: 2012-06-11

Rebeccamycin Analog as Second-Line Therapy in Treating Patients With Limited-Stage or Extensive-Stage Small Cell Lung Cancer That Relapsed After Previous First-Line Chemotherapy

TerminatedNCT00084487

National Cancer Institute (NCI)Extensive Stage Small Cell Lung Cancer, Limited Stage Small Cell Lung Cancer, Recurrent Small Cell Lung Cancer

Start: 2004-04-30End: 2008-04-30Updated: 2014-05-23

Phase 3

XL119 Versus 5-Fluorouracil (5-FU) Plus Leucovorin (LV) in Subjects With Advanced Biliary Tumors

TerminatedNCT00090025

Helsinn Healthcare SABiliary Tract Cancer

Start: 2004-09-30End: 2006-11-30Updated: 2009-01-14